NASDAQ$VREX
Varex Imaging Corp · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
Reported strong revenue growth driven by higher global sales of CT tubes and products for oncology, dental and airport baggage screening applications.
Varex Imaging Corporation announced an 8% increase in revenues for the first quarter of fiscal year 2020, reaching $200 million compared to $186 million in the prior year quarter. The growth was driven by strong sales in CT tubes and products for oncology, dental, and airport baggage screening applications.
- Revenues for the first quarter of fiscal year 2020 increased 8% to $200 million compared to $186 million in the prior year quarter.
- Medical segment revenues increased 8% to $156 million.
- Industrial segment revenues increased 6% to $44 million.
- Net earnings for the first quarter of fiscal year 2020 were $(0.03) per diluted share compared to $0.08 per diluted share in the prior year quarter.
Headline financials
Revenue & EPS history
Varex Imaging · Revenue · Quarterly
$200M
Revenue by segment
Varex Imaging · $200M total across 2 segments · Q1 2020
- Medical$156M+980.0%78.0%
- Industrial$44M—22.0%
Forward guidance
No forward guidance was given in this report.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2020
-4.3%
Avg return
Earnings day
-3.4%
Avg return
5 days after
-3.0%
Avg return
30 days after
37%
15 / 41 earnings
Positive
+22.1%
Q1 2021
Best reaction
-34.7%
Q2 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | -16.9% | -14.9% | — | |
| Q1 2026 | -3.8% | -4.5% | -23.6% | |
| Q4 2025 | -13.7% | -7.1% | +3.6% | |
| Q2 2025 | -20.5% | -13.9% | -2.7% | |
| Q1 2025 | -19.3% | -11.6% | -15.7% | |
| Q4 2024 | +9.2% | +17.8% | +1.8% | |
| Q3 2024 | -12.2% | -21.2% | -15.6% | |
| Q2 2024 | -6.0% | -4.4% | -6.8% | |
| Q1 2024 | -8.4% | -8.4% | -8.6% | |
| Q4 2023 | +3.1% | +1.7% | +12.7% | |
| Q3 2023 | -3.8% | -2.6% | -15.5% | |
| Q2 2023 | +17.6% | +25.5% | +25.6% | |
| Q1 2023 | -10.0% | -7.2% | -14.6% | |
| Q4 2022 | +3.8% | -1.6% | -10.7% | |
| Q3 2022 | +4.1% | -0.6% | -0.3% | |
| Q2 2022 | +11.5% | +11.5% | +15.8% | |
| Q1 2022 | -5.3% | -8.6% | -4.8% | |
| Q4 2021 | +17.1% | +15.0% | +8.7% | |
| Q3 2021 | +1.9% | +7.3% | +10.2% | |
| Q2 2021 | +2.6% | +2.0% | +6.1% | |
| Q1 2021 | +22.1% | +19.3% | +21.0% | |
| Q4 2020 | -3.2% | +1.0% | +16.6% | |
| Q3 2020 | -21.2% | -21.1% | -34.3% | |
| Q2 2020 | -34.7% | -32.9% | -38.3% | |
| Q1 2020 | -5.3% | -5.3% | -25.3% | |
| Q4 2019 | -9.7% | -7.5% | -3.5% | |
| Q3 2019 | -15.8% | -13.3% | -5.0% | |
| Q2 2019 | -9.1% | -8.1% | -16.4% | |
| Q1 2019 | +15.7% | +8.8% | +15.0% | |
| Q4 2018 | -8.3% | -1.8% | -10.8% | |
| Q3 2018 | -25.7% | -25.5% | -17.8% | |
| Q2 2018 | -1.6% | -0.3% | +1.1% | |
| Q1 2018 | -18.5% | -15.9% | -15.8% | |
| Q4 2015 | -1.2% | -0.2% | +7.2% | |
| Q4 2017 | +1.8% | +2.6% | +10.3% | |
| Q3 2016 | +0.8% | -0.2% | +9.4% | |
| Q3 2017 | -8.2% | -5.1% | +1.3% | |
| Q2 2016 | +0.2% | +0.2% | -3.3% | |
| Q2 2017 | +0.7% | +1.2% | +3.0% | |
| Q1 2017 | -2.4% | -5.1% | -0.3% | |
| Q4 2016 | -2.4% | -5.1% | -0.3% | |
| Q1 2016 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro